Journal Article

Follow-up and Analysis of Helicobacter pylori Antibioic Resistance in the South Area of Sichuan Province

Get access
The Journal of Infectious Diseases, Volume 232, Issue Supplement_4, 15 November 2025, Pages S418–S424, https://doi.org/10.1093/infdis/jiaf402
Published:
20 November 2025

Abstract

Background

The antibiotic resistance rate of Helicobacter pylori (H. pylori) has increased year by year with the widespread use of antibiotics, resulting in reduced efficacy of eradication therapy and increased recurrence rate. We conducted a survey on H. pylori resistance in the South area of Sichuan province to provide guidance for front-line treatments of H. pylori in this area.

Methods

Helicobacter pylori strains were isolated from gastric mucosa specimens obtained from patients with suspected H. pylori infection from the South area of Sichuan province. Antibiotic susceptibility of the strains was determined by disk diffusion method.

Results

Among 373 patients, 323 were from southern Sichuan. H. pylori strains were isolated and cultured from gastric mucosa samples of 304 patients, resulting in an isolation and culture success rate of 81.50%. Metronidazole (MNZ) is the antibiotic with the highest drug resistance rate in the South area of Sichuan province, with a drug resistance rate as high as 98.68%. The resistance rates of amoxicillin and furazolidone were very low, accounting for 0.29% and 0.99%, respectively. However, tetracycline showed no resistance. Single antibiotic resistance accounted for 35.67%, while the resistance to 2 antibiotics was dual resistance, accounting for 34.67%. Dual drug resistance was mainly MNZ and levofloxacin, followed by MNZ and clarithromycin (CLA).

Conclusions

MNZ, levofloxacin, and CLA should be used cautiously in H. pylori eradication therapy in the South area of Sichuan province. If the cultivation results and drug sensitivity test results of the H. pylori strain cannot be obtained, it is recommended to adopt an empirical treatment plan, using the pairwise combinations of amoxicillin, tetracycline, and FZD, especially the combination of amoxicillin and tetracycline.

This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://dbpia.nl.go.kr/pages/standard-publication-reuse-rights)
You do not currently have access to this article.
Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close

Gift article access

As a benefit of your subscription, you can share temporary access to restricted articles.

Each link will stop working after 30 days or 10 uses. You may create up to 10 links in a 30 day period.

Please sign in to your personal account to gift article access.

Gift article access

Please create a link below to share with others. This will provide temporary access to this restricted article.

The link will stop working after 30 days or 10 uses. You may create up to 10 links in a 30 day period.

Gift articles remaining: --

Gift article access

The link will stop working after 30 days or 10 uses. You may create up to 10 links in a 30 day period.

Gift articles remaining: --

Gift article access

As a benefit of your subscription, you can share temporary access to restricted articles.

Each link will stop working after 30 days or 10 uses.

You have reached the limit of 10 links within a 30 day period